180593-41-3 Usage
Description
(4-Hydroxy-phenyl)-methyl-carbamic acid tert-butyl ester, also known as Tert-butyl 4-(hydroxyphenyl)methylcarbamate, is an organic compound characterized by its chemical formula C12H17NO3. It is a tert-butyl ester derivative of (4-hydroxyphenyl)methylcarbamic acid, which is recognized for its significant role as a pesticide and herbicide in the agricultural sector.
Uses
Used in Agricultural Applications:
(4-Hydroxy-phenyl)-methyl-carbamic acid tert-butyl ester is used as a pesticide and herbicide for controlling various pests and weeds in farming. Its application is attributed to its ability to inhibit the activity of acetylcholinesterase, an enzyme crucial to the central nervous system of insects, which results in paralysis and death of the pests.
Due to the potential toxicity and environmental impact of (4-Hydroxy-phenyl)-methyl-carbamic acid tert-butyl ester, its use is regulated under strict guidelines and restrictions in many countries to ensure the safety of the environment and public health.
Check Digit Verification of cas no
The CAS Registry Mumber 180593-41-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,5,9 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 180593-41:
(8*1)+(7*8)+(6*0)+(5*5)+(4*9)+(3*3)+(2*4)+(1*1)=143
143 % 10 = 3
So 180593-41-3 is a valid CAS Registry Number.
180593-41-3Relevant articles and documents
N-Methyl- N-phenylvinylsulfonamides for Cysteine-Selective Conjugation
Huang, Rong,Li, Zhihong,Sheng, Yao,Yu, Jianghui,Wu, Yue,Zhan, Yuexiong,Chen, Hongli,Jiang, Biao
, p. 6526 - 6529 (2018)
Use of N-methyl-N-phenylvinylsulfonamides to perform chemoselective modification of cysteine-containing peptides and proteins is reported. Probes linked to the drug were applicable to prepare antibody-drug conjugates (ADCs). The drug-antibody ratio for AD
SUBSTITUTED QUINOLINES AND METHODS FOR TREATING CANCER
-
Paragraph 0301, (2018/05/24)
Substituted quinoline compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or ameliorate cancer are provided.
